XML 64 R53.htm IDEA: XBRL DOCUMENT v3.25.2
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2024
USD ($)
Jun. 30, 2024
EUR (€)
Nov. 30, 2020
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Aug. 31, 2024
USD ($)
Dec. 31, 2022
USD ($)
Jun. 30, 2022
USD ($)
May 31, 2022
USD ($)
Nov. 30, 2021
USD ($)
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Research and development       $ 2,050,585 $ 587,503 $ 4,424,724 $ 1,472,801          
Research and consulting agreement | Therapeutics Inc.                        
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Research and development       348,000 $ 162,000 759,000 $ 650,000          
Research and consulting agreement | Scleroderma                        
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Total amount of agreement                     $ 610,000  
Research and consulting agreement | The School of Pharmacy at UCC                        
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Maximum funding amount $ 668,000 € 567,000                    
Commitment period 2 years 6 months 2 years 6 months                    
Accrued research and development expense       $ 60,000   $ 120,000            
Consulting agreements | Netherton Syndrome                        
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Total amount of agreement                       $ 250,000
Consulting agreements | Therapeutics Inc.                        
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Initial term     3 years                  
Written termination notice period     90 days                  
Total amount of agreement               $ 3,600,000 $ 830,000 $ 4,400,000